Effective management and intrauterine treatment of congenital cytomegalovirus infection: Review article and case series

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 27, Issue 2, 2014, Pages 209-214

  Wagner, Norbert ^a,f   Kagan, Karl Oliver ^b   Haen, Susanne ^b   Schmidt, Sybille ^c   Yerlikaya, Gülen ^d   Maden, Zerrin ^e   Jahn, Gerhard ^b   Hamprecht, Klaus ^b  

^a Department of Obstetrics and Gynecology ^*  (Germany)

^b University Hospital of Tuebingen   (Germany)

^c UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^d UNIVERSITY OF VIENNA   (Austria)

^e KLINIKEN ESSEN MITTE   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

CMV; Fetal outcome; Hyperimmune globulin therapy; Intrauterine infection; Ultrasound

Indexed keywords

HYPERIMMUNE GLOBULIN; PROTEIN ANTIBODY;

ADULT; AMNION FLUID; ANTIGEN ANTIBODY REACTION; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONGENITAL INFECTION; CYTOMEGALOVIRUS INFECTION; DRUG EFFECT; FEMALE; FEVER; GESTATIONAL AGE; HUMAN; IMMUNOTHERAPY; MULTIGRAVIDA; OUTCOME ASSESSMENT; PREGNANCY OUTCOME; PREGNANCY TERMINATION; PRIMARY INFECTION; PRIMIGRAVIDA; PRIMIPARA; PRIORITY JOURNAL; SEROLOGY; TREATMENT PLANNING; YOUNG ADULT;

ADULT; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA, VIRAL; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULINS; IMMUNOGLOBULINS, INTRAVENOUS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 84890505896     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.806899     Document Type: Article

References (25)

1. Nigro G, Adler SP, La Torre R, et al. Passive immunization during pregnancy for congenital Cytomegalovirus infection. N Engl J Med 2005;353:1350-62. (Pubitemid 41362703)
2. La Torre R, Nigro G, Mazzocco M, et al. Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease. Clin Infect Dis 2006; 43:994-1000. (Pubitemid 44631098)
3. Maidji E, Nigro G, Tabata T, et al. Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection. Am J of Pathol 2010;177:1298-310.
4. Bissinger AL, Sinzger C, Kaiserling E, Jahn G. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol 2002; 67:200-6. (Pubitemid 34493433)
5. Goegebuer T, Van Meensel B, Beuselinck K, et al. Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples. J Clin Microbiol 2009;47:660-5.
6. Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol 2007;17:253-76. (Pubitemid 47066638)
7. Berger A, Reitter A, Harter PN, et al. Problems and challenges in the diagnosis of vertical infection with human cytomegalovirus (CMV): lessons from two accidental cases. J Clin Virol 2011;51: 285-8.
8. Abdel-Fattah SA, Bhat A, Illanes S, et al. TORCH test for fetal medicine indications: only CMV is necessary in the United Kingdom. Prenat Diagn 2005;25:1028-31. (Pubitemid 41745682)
9. Cheeran MCJ, Lohensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease, mechanisms and prospects for intervention. Clin Microbiol Rev 2009;22: 99-126.
10. Benoist G, Salomon LJ, Jacquemard F, et al. The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus. BJOG 2008;115: 823-9. (Pubitemid 351692993)
11. Guerra B, Simonazzi G, Puccetti C, et al. Ultrasound prediction of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2008;198:380.e1-7.
12. Moxley K, Knudtson EJ. Resolution of hydrops secondary to cytomegalovirus after maternal and fetal treatment with human cytomegalovirus hyperimmune globulin. Obstet Gynecol 2008;111: 524-6. (Pubitemid 351156486)
13. Moise KJ, Wolfe H. Treatment of second trimester fetal cytomegalovirus infection with maternal hyperimmune globulin. Prenat Diagn 2008;28:264-5. (Pubitemid 351427951)
14. Nigro G, La Torre R, Pentimalli H, et al. Regression of fetal cerebral abnormalities by primary catomegalovirus infection following hyperimmunoglobulin therapy. Prenatal Diagn 2008;28: 512-17. (Pubitemid 351946953)
15. Pass RF, Zhang C, Evans A, et al. Vaccine prevention of maternal cytomegalovirus infection. N Engl J Med 2009;360:1191-9.
16. Jacquemard F, Yamamoto M, Costa JM, et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG 2007;114:1113-21. (Pubitemid 47247017)
17. Cannon MJ, Davis KF. Washing our hands of the congenital cytomegalovirus disease epidemic. BMC Publ Health 2005;20:70-77.
18. Vauloup-Fellous C, Picone O, Cordier AG, et al. Does hygiene counselling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital. J Clin Virol 2009;46S:S49-53.
19. Grangeot-Keros L, Mayaux MJ, Lebon P, et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J Infect Dis 1997;175: 944-6. (Pubitemid 27142973)
20. Rothe M, Pepperl-Klindworth S, Lang D, et al. An antigen fragment encompassing the AD2 domains of glycoprotein B from two different strains is sufficient for differentiation of primary vs. recurrent human cytomegalovirus infection by ELISA. J Med Virol 2001;65:719-29. (Pubitemid 33135101)
21. Eggers M, Bäder U, Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000;60:324-30. (Pubitemid 30054287)
22. Revello MG, Furione M, Zavattoni M, et al. Human cytomegalovirus (HCMV) DNAemia in the mother at amniocentesis as a risk factor for iatrogenic HCMV infection of the fetus. J Infect Dis 2008; 197:593-6. (Pubitemid 351321538)
23. Lazzarotto T, Guerra B, Lanari M, et al. New advances in the diagnosis of congenital cytomegalovirus infection. J Clin Virol 2008;41:192-7. (Pubitemid 351246738)
24. Adler SP, Nigro G. The importance of cytomegalovirus-specific antibodies for the prevention of fetal cytomegalovirus infection or disease. Herpes 2008;15:24-7.
25. Adler SP, Nigro G. Findings and conclusions from CMV hyperimmune globulin treatment trials. J Clin Virol 2009;46:S54-7.